Podcasts about ce podcast

Bienvenue dans la nouvelle série d'épisodes spécial "interview aux anciens membres de Sí comprendo".Aujourd'hui j'ai la chance d'avoir un de mes meilleurs élèves. Il partage son parcours de débutant absolu en espagnol à intermédiaire. Il a commencé avec des méthodes autodidactes, jusqu'à ce qu'il a compris qu'il avait besoin d'être accompagné pour aller plus loin.

Découvrez ma formation en ligne sur les fondamentaux de l'accueil !Chers Insiders, Notre voyage dans l'expérience et l'excellence de service continue et je me réjouis de rencontrer des invités toujours plus passionnants. Ce Podcast n'en est encore qu'à son commencement, mais les retours que vous me partagez m'encouragent à continuer ce beau projet. Si vous souhaitez que j'aille à la rencontre de personnalités remarquables, dites-le moi sur mes différents réseaux et partons ensemble à leur rencontre. Je suis Maxime Blot, artisan hôtelier, et vous êtes sur Hospitality Insiders. Mon invité du jour est un expert du Marketing et de la communication, quoi de mieux pour compléter notre vision de l'expérience client ? Il a également une longue carrière dans l'entrepreneuriat et je peux dire sans me tromper que le développement durable est une valeur forte que nous partageons. Je suis heureux de l'accueillir et je me languis d'en savoir plus sur son parcours, bonjour Olivier Dufit. Notes et références : La coopérative The Originals, Human Hotels & Resorts Travelclick, fournisseur mondial de solutions pour les hôteliers OTA : Online Travel Agency GDS : Global Distribution System LMS : Learning Management System RSE : Responsabilité Sociétale des Entreprises PMS : Property Management System Livre : les quatre accords toltèques de Don Miguel Ruiz Linkedin : Olivier Dufit Email : olivier_dufit@yahoo.frSi cet épisode vous a passionné, rejoignez-moi sur :L'Hebdo d'Hospitality Insiders, pour ne rien raterL'Académie Hospitality Insiders, pour vous former aux fondamentaux de l'accueilLinkedin, pour poursuivre la discussionInstagram, pour découvrir les coulissesLa bibliothèque des invités du podcastMerci de votre fidélité et à bientôt !Distribué par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Nombre d'étudiants se demandent comment pratiquer son espagnol avec les natifs pour débloquer leur oral ou pour entretenir leur niveau après avoir suivi une formation.Même si ce type d'échanges linguistiques ne remplacent en aucun cas le suivi d'un professeur expert, cela peut être une excellente manière de compléter ton apprentissage et de rester motivé dans la durée.Dans cet épisode je te lis une histoire active sur l'application "Senior Lingua", qui permet de participer à des échanges linguistiques avec des personnes âgées en Espagne. C'est une formule gagnant-gagnant: tu pratiques ton espagnol, et tu aide ces personnes à se sentir moins seules.Découvre l'application ici.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/characterizing-connected-conditions-in-psychiatry-10045SummaryIn this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Lisa Harding discuss some of the complexities of mental health care: overlapping symptoms and differential diagnoses. Listeners will learn about the connections between certain psychiatric disorders and how symptom combinations may influence treatment and patient outcomes. The program will also review strategies to help with accurate diagnoses in complex patient presentations, teaching listeners how to take a thorough patient history and use that information to guide treatment decisions.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Describe the impact of comorbid mental health diagnoses on patient outcomesEmploy strategies to aid in the differential diagnosis of patients who present with symptoms suggestive of multiple mental health conditionsThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/practical-management-for-complex-psychiatric-cases-10046SummaryIn this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Lisa Harding teach by case example. Listeners will hear an introduction to a complex patient presentation and then be taken through expert strategies to discern the correct diagnoses. The program will conclude with the same case example to tie together the education and demonstrate these strategies in practice.This podcast was recorded and is being used with permission of the presenters.Learning ObjectiveAt the conclusion of this activity, participants should be better able to:Apply evidence-based strategies to develop personalized treatment plans when managing patients with comorbid mental health disordersThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which does not include hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Voici un extrait de la FÊTE DU PRINTEMPS que j'ai animé le dimanche 30 mars pour tous les abonnés à la newsletter.Ils on pu tester leurs connaissances d'espagnol avant de partir, et puis je leur ai présenté la nouvelle ÉDITION EN DIRECT DE "ESPAGNOL POUR VOYAGER".Je partage avec toi aujourd'hui un extrait qui te permettra d'expériementer le pouvoir des histoires pour acquérir les bases de l'espagnol naturellement avant de partir en voyage.Offre-toi cette expérience linguistique avant le 2 avril 2025 ici.(Si jamais tu écoutes cet épisode plus tard, tu pourras te procurer la version en autonomie tout de même qui te permettra également de faire tes premiers pas en espagnol de façon complètement libre et à ton rythme).

Dans ce podcast de la saison 2, nous reprenons le projet de podcast mais cette fois-ci directement sur Division Canine.

Je suis Anne Margalin, Créatrice de l'univers de Sweet Papi Podcast, fondatrice d'un centre de ressources positives pour les aidants où nous prenons soin de nous et de nos parents en perte d'autonomie, avec bienveillance et sourire 

✨ Rien n'est impossible à ceux qui rêvent assez grand. À vos rêves. ✨Aujourd'hui, je suis un petit peu émue de me relancer dans des épisodes solo. Après 7 ans de podcast, c'est un vrai retour aux sources. Les temps ont changé. Je change, j'évolue. Et j'ai envie de retrouver cet espace où je peux partager avec vous, sans filtre.Quand j'ai lancé ce podcast, j'étais concentrée à 400% sur Gemmyo. Mais j'avais besoin de me lancer dans autre chose que ma vie professionnelle. Ce podcast m'a complètement allégée à l'époque. Il m'a permis de prendre du recul, de réfléchir autrement.Les interviews ne disparaissent pas, loin de là mais j'ai aussi envie de vous parler directement, de vous emmener avec moi dans mes réflexions.Dans cet épisode, je partage avec vous 2 habitudes qui ont profondément changé ma manière de vivre et de travailler. Rien d'extravagant vous allez me dire, mais des ajustements simples qui ont eu un impact immense au fil du temps.Dites-moi si ce format vous plaît, si vous souhaitez m'entendre plus souvent en solo. Ce podcast existe grâce à vous, et vos retours sont précieux.Bonne écoute !

Dans cet épisode vibrant de Percevoir Autrement, François Lemay t'invite à plonger au cœur du noting – ce vide sacré, ce champ de pure potentialité où tout est possible. À travers une guidance inspirante et un enseignement profond, tu découvriras pourquoi ta plus grande puissance réside dans ta capacité à choisir où tu mets ton attention. ✨ À découvrir dans cet épisode :

Hey!! j'espère que vous allez bien ! j'espère également que cette annonce ne vous déçois pas trop trop!répondez vraiment au sondage ou dites moi ce que vous en pensez dans les commentaire!!Bonne écoute!#kpop #end #podcast #thekpoptime

Voici un extrait de la MASTERCLASS "Automatiser les verbes fréquents pour des conversations plus fluides et sans blocages".Je t'explique comment les 4 schémas du modèle INSIGHTS peuvent s'appliquer à ton apprentissage de l'espagnol.Deviens BETA-TESTEUR du BUNDLE "DÉFI DE CONJUGAISON + GRAMÁTICA NO DRAMÁTICA" (offre flash disponible jusqu'au jeudi 13 mars 2025 à 12h heure de Paris).

Témoignage consommateur de Valérie C.G., interviewée par Eric lors d'une Visio le 20 Février 2025.---Valérie, 56 ans, est auxiliaire de vie, pétillante et pleine d'énergie… mais il y a quelques mois, elle était à bout ! Son corps lui envoyait des signaux d'alerte : impossible de prendre son petit-déjeuner, des crampes nocturnes insupportables, des bouffées de chaleur, une fatigue écrasante… et ces 10 kilos en trop qui la ralentissaient.Puis tout a changé ! Invitée à dîner chez des amis, elle découvre Kriss-Laure… et c'est une évidence : c'est pour elle ! Dès les premiers jours, fini les nausées, plus aucune sensation de faim, une digestion parfaite. En quelques semaines, son corps se transforme sans effort : 10 kg envolés, plus de crampes, plus de bouffées de chaleur, et surtout… un regain d'énergie incroyable !Aujourd'hui, Kriss-Laure est devenu "la cerise sur le gâteau de sa vie". Valérie ne regrette qu'une seule chose : ne pas avoir connu ces produits plus tôt !Comme elle le dit si bien : "Il n'y a pas de hasard. Si vous êtes ici, c'est que c'est le moment pour vous. Foncez !"----Gammes Consommées : Entremets, Tonic, repas Idée Délice----Inscrivez-vous pour suivre notre prochain webinaire "Enfin dire stop à la reprise de poids", le lundi 03/03/2025 à 20h : https://streamyard.com/watch/8XzBAH8E4QiXHébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/on-the-lookout-for-eoe-9990SummaryIn this CME/CE podcast, two gastroenterologists discuss the increasing prevalence of eosinophilic esophagitis (EoE), our evolving understanding of its pathophysiology, and its varied clinical presentation. Drs. Brooks Cash and Paul Feuerstadt also review the need for early identification of the condition, and discuss the latest American College of Gastroenterology guideline for diagnosis.Learning ObjectiveAt the conclusion of this activity, participants should be better able to:Identify common clinical presentations and diagnostic challenges to facilitate early diagnosis of EoE in diverse patient populationsThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.50 contact hours (which includes 0 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/management-approaches-for-eoe-9991SummaryThe American College of Gastroenterology has published the first new guidelines for the treatment of eosinophilic esophagitis (EoE) since 2013. In this CME/CE podcast, Drs. Paul Feuerstadt and Brooks Cash discuss these latest recommendations, reviewing the role of proton pump inhibitors, topical steroids, diet elimination, a biologic, and esophageal dilation in the management of this increasingly recognized condition.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Assess the efficacy and safety profile of approved agents for EoE, with a focus on swallowed corticosteroids, in the management of EoEApply evidence-based guidelines to optimize treatment outcomes and improve the quality of life for patients with EoEThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.50 contact hours (which includes 0.25 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Fêtons l'épisode nº80 avec un nouveau quiz qui récapitule les contenus des épisodes 71-79, cette fois-ci en format DIRECT SUR YOUTUBE!S'abonner à la newsletter.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/exercise-for-mental-health-9983SummaryWe've heard it time and time again, exercise is of great importance to our physical health—but did you know it is also important to our mental health? An activity as simple as taking a daily walk can have a substantial positive impact on depression outcomes. Despite the widespread benefits of exercise, patients and providers may overlook its importance in treatment plans. This presentation focuses on the mental and physical benefits of exercise, drawing insights from published data and clinical experience.In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Gerald Maguire discuss the benefits of exercise on both physical and mental health. Throughout the episode, they go through the research that supports the benefits of exercise, as well as provide practical strategies to encourage your patients to adopt exercise into their lifestyles.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Describe the impact of exercise on mental healthReview data from prospective studies investigating the relationship between exercise and depressionThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/psychedelics-for-depression-9984SummaryIn this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Gerald Maguire explore the emerging role of psychedelics in treating mental health conditions. Listeners will learn about the mechanisms of action of psychedelic therapeutics and gain insights into their effects on the brain and behavior. The program will also review recent clinical trial data on the efficacy of psychedelic treatments for major depressive disorder (MDD), as well as provide expert insights on how to discuss the future of psychedelics with patients.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Describe the mechanism of action of psychedelic therapeuticsReview clinical trial data regarding the use of psychedelic treatments in MDDThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.75 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Je m'inscris à la newsletter https://www.fundamentaconsulting.fr/newsletter//

Aujourd'hui, je te retrouve avec un épisode un peu particulier sur Petite Pousse, le podcast où le marketing rencontre le développement personnel. Je suis Eleonore et je suis ravie de partager un nouvel angle avec toi pour l'année 2025 : recentrer notre attention sur des épisodes solo enrichis de réflexions personnelles. Dans cet épisode, je te dévoile les changements à venir concernant la ligne éditoriale du podcast. J'ai envie de m'éloigner des interviews nombreuses que j'ai faites en 2024 pour laisser davantage de place aux épisodes solo. Ces derniers sont souvent vos préférés et il est vrai que partager mes expériences de vie, mes découvertes et mes apprentissages au quotidien me passionne et, je l'espère, résonne aussi en toi.L'idée est de donner une nouvelle dimension à Petite Pousse, un format proche du vlog, mais en version audio, où je discuterai de sujets allant bien au-delà du marketing. Que ce soit dans ma vie d'entrepreneuse, de maman, ou encore d'épouse, je vais te parler à cœur ouvert de tout ce qui m'interpelle. En parallèle, je compte introduire un format questions-réponses : soit via vos interrogations envoyées sur Instagram ou LinkedIn, soit directement en live avec toi, cher auditeur ou auditrice, pour des échanges personnalisés et inspirants.J'ai hâte de te partager tout cela en 2025 et de voir comment cela résonne avec toi. Si tu as des questions ou des sujets que tu aimerais me voir aborder, dis-le-moi sur LinkedIn ou Instagram !> Pour me retrouver :Guide offert “les 9 étapes pour vous créer une stratégie de communication puissante et alignée” : www.authentic.nc/guide-offertSite web : https://authenticommunication.frProfil LinkedinProfil Instagram Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

Dans cet épisode je partage avec toi ma méthode en 3 pas facile et progressive pour retrouver le contrôle de ton agenda et réussir enfin à trouver le temps de te mettre à l'espagnol.Pour écouter la suite de l'audio-training gratuit, c'est par ici.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/managing-the-burden-of-hyperkalemia-9952SummaryIn this concise CME/CE podcast, a cardiologist and a family physician discuss risks associated with hyperkalemia in patients being treated for heart failure or chronic kidney disease (CKD)—including the risks that accompany down-titration or discontinuation of RAASi therapy.Drs. Javed Butler and Neil Skolnik provide guidance on which patients are most at risk and review the use of potassium binders that can manage hyperkalemia without compromising the crucial use of guideline-directed medical therapy (GDMT). By the end of this podcast episode, listeners will feel much more confident in their ability to safely and effectively address hyperkalemia in patients with heart failure or CKD.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Describe the disparities and clinical implications of hyperkalemia in patients with HF and CKD in terms of optimizing guideline-directed medical therapy (GDMT) and outcomesDiscuss the safety and effectiveness of potassium binders in reducing potassium and optimizing GDMT in patients with HF and CKDThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is supported by an educational grant from AstraZeneca Pharmaceuticals.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/using-newer-agents-in-chronic-hyperkalemia-management-9953SummaryIn this concise CME/CE podcast, a cardiologist and primary care physician review hyperkalemia management options that safely allow continuing GDMT for patients with heart failure or CKD. Using case examples, the clinicians provide education on individualizing treatment and addressing disparities in care.Learning ObjectiveAt the conclusion of this activity, participants should be better able to:Identify practical aspects of using potassium binders for treating hyperkalemia and optimizing GDMT to achieve equitable care for patients with HF and CKDThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is supported by an educational grant from AstraZeneca Pharmaceuticals.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/tick-tock-psych-expert-tips-on-complex-patient-management-9943SummaryMore often than not, patients present to clinicians with multiple diagnoses—complicating treatment decisions. Whether the comorbidities are related to psychiatric, cardiovascular, or neurologic etiologies, psychiatry clinicians need to know how to optimally manage patients in the face of such challenges. This presentation provides quick, to-the-point answers to audience questions regarding complex patient management.In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Gerald Maguire go against the clock to answer your questions on complex patient management in the psychiatry setting. They are given 2 minutes to answer each question, packing their expertise into small, bite-sized sections.This podcast was recorded and is being used with permission of the presenters.Learning ObjectiveAt the conclusion of this activity, participants should be better able to:Discuss psychiatric management considerations for patients with complex comorbidities in your clinical practice.This activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.25 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/breakthroughs-of-mental-health-advances-9942SummaryWe saw a lot of changes in 2024, especially in the mental health/psychiatry space. Keeping up with the most current information and how it affects your practice can be challenging in this ever-changing landscape. This presentation aims to make this information more accessible to clinicians so that patients can receive the most up-to-date care.In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Gerald Maguire wrap up 2024 with a question-and-answer session focused on the latest advances in the mental health field. Listen as they go through questions covering major depressive disorder, ADHD, bipolar disorder, and schizophrenia.This podcast was recorded and is being used with permission of the presenters.Learning ObjectiveAt the conclusion of this activity, participants should be better able to:Review the latest advances in ADHD, MDD, bipolar disorder, and schizophreniaThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which includes 0.50 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Fais connaissance avec la nouvelle enseignante de l'équipe: ma soeur!Teste ton niveau d'espagnol avec ce dialogue 100% en espagnol adapté aux débutants.➡️ Le QUIZ INTERACTIF

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/adult-adhd-diagnosis-and-management-9854SummaryAdult ADHD is a neurodevelopmental disorder that often persists from childhood into adulthood, affecting attention, impulsivity, and executive function. Despite increased awareness, ADHD in adults remains underdiagnosed and undertreated, presenting unique challenges in clinical practice. This presentation focuses on strategies to address these challenges, drawing insights from recent data and provides our experts recommendations.In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss key findings from the CDC report on adult ADHD, including trends in prevalence, diagnostic gaps, and barriers to effective treatment. They also explore the latest research on gender differences in ADHD, emphasizing how these disparities impact diagnosis and treatment approaches. Our experts highlight the need for tailored strategies to ensure more accurate and effective care, especially given that women are often diagnosed later in life and may experience different symptom presentations than men.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Review key insights from the CDC report regarding the prevalence, diagnosis trends, and treatment challenges of ADHD in adultsExamine the latest data on gender differences in ADHD diagnosis and treatmentThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/streamlined-strategies-for-managing-tardive-dyskinesia-9842SummaryTardive dyskinesia (TD) is a debilitating movement disorder that manifests as involuntary, repetitive movements, often of the face, tongue, and extremities. These symptoms frequently result from prolonged use of antipsychotic medications, particularly in patients being treated for schizophrenia, bipolar disorder, or major depressive disorder. Accurate and routine assessment of TD is critical to prevent symptom progression and improve patient outcomes. The Abnormal Involuntary Movement Scale (AIMS) is a widely accepted, gold-standard tool used to detect and measure the severity of involuntary movements. AIMS enables clinicians to detect involuntary movements early and track the disorder's progression, facilitating timely intervention and individualized treatment plans.In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic delve into the complexities of diagnosing and managing tardive dyskinesia (TD), emphasizing evidence-based strategies to improve patient outcomes. They discuss the importance of using the Abnormal Involuntary Movement Scale (AIMS), a standardized and validated tool, for regular TD assessment. AIMS enables clinicians to detect involuntary movements early and track the disorder's progression, facilitating timely intervention and individualized treatment plans.Learning ObjectiveAt the conclusion of this activity, participants should be better able to:Explore strategies to simplify management and optimally improve outcomes for patients with TDThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.50 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is supported by an educational grant from Neurocrine Biosciences.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Le 29 octobre 2024 il s'est produit une vraie catastrophe naturelle dans la région de Valence en Espagne.Qu'est-ce qu'une DANA?Pourquoi cet événèment s'est fini par une crise humanitaire?Découvre les actualités de l'Espagne grâce à cette histoire en espagnol compréhensible.➡️ Le QUIZ INTERACTIF

This podcast features an engaging discussion between Dr. Douglas Dieterich and his patient with long-standing PBC, on the patient's insights and experiences with her disease and treatment. The activity will enable participants to understand the importance of listening to patient perspectives when designing individualized care pathways to alleviate symptoms and improve quality of life.Launch Date: November 21, 2024Release Date: November 21, 2024Expiration Date: October 31, 2025FACULTYDouglas Dieterich, MDDirector, Institute for Liver Medicine at Mount SinaiProfessor of Medicine, Icahn School of Medicine at Mount SinaiThis podcast provides accredited continuing education credits.  To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.https://www.practicepointcme.com/CMEHome/patient-voices-in-primary-biliary-cholangitis-a-ce-podcast-series-to-recognize-challenges-reduce-disparities-and-improve-outcomes

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/leaky-gut-leaky-brain-addressing-gut-brain-axis-9815SummaryThough it is widely acknowledged that the gut is our largest endocrine and immune organ, its role in brain health is less well-known. When is the last time you asked a patient with depression about their diet? Mental health care expands beyond pharmacologic treatment, as explained in this activity detailing the influence of the gut-brain axis on neuroinflammation and the role that diet and pre/probiotics can play in mental health treatment.In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss the gut-brain axis and its influence on brain health, from its role in the manifestation of certain brain disorders and how we can target the gut to ultimately improve patient outcomes in psychiatry.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Identify the key mechanisms of the gut-brain axis influence on brain disorders.Discuss ways of incorporating understanding of gut dysbiosis into comprehensive treatment of psychiatric disorders.This activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially funded.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/management-of-amyloid-cardiomyopathy-and-polyneuropathy-9813SummaryIn this CME/CE podcast episode, Cardiologist Dr. Michelle Kittleson and Neurologist Dr. Chafic Karam discuss the multidisciplinary management of transthyretin amyloidosis (ATTR). They explore how ATTR affects both the heart and the nervous system, focusing on recognizing symptoms, diagnosing the disease, and managing treatment. Dr. Karam shares insights on peripheral neuropathy caused by amyloidosis, including clues that suggest amyloidosis over more common neuropathies. Dr. Kittleson highlights how cardiologists assess and manage TTR cardiomyopathy, emphasizing the importance of early diagnosis and the evolving therapeutic landscape. Together, they discuss the collaborative nature of care, the impact of new therapies on clinical outcomes, and the importance of raising awareness for ATTR.Learning ObjectivesDescribe the correct diagnostic algorithm for suspected ATTR, including interpretation of the monoclonal protein screen and indications for biopsy and genetic testingInitiate appropriate management, including disease-directed therapy and appropriate cardiac care, or referral when indicatedThis activity is accredited for CME/CE CreditAssociation of Black Cardiologists, Inc. (ABC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Association of Black Cardiologists, Inc. designates this enduring material for a maximum of 0.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and ABC. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.25 contact hours (which does not include hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is supported by an educational grant from Alnylam Pharmaceuticals Inc., and an educational grant from AstraZeneca Pharmaceuticals.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Apprends la signification de cette expression en espagnol dans un épisode 100% en espagnol adapté à un niveau A2.Offre-toi l'atelier linguistique "20 expressions idiomatiques en espagnol"

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/vmat2-inhibitors-in-tardive-dyskinesia-9799SummaryTardive dyskinesia (TD) is a syndrome characterized by various iatrogenic movement disorders resulting from dopamine receptor antagonism. These movement disorders include akathisia, dystonia, buccolingual stereotypy, chorea, tics, and other abnormal involuntary movements, most commonly emerging after prolonged antipsychotic use.Vesicular monoamine transporter type 2 (VMAT2) inhibitors are now available in the United States for managing dyskinesia syndromes, each with a slightly different range of approved indications. VMAT2 inhibitors are agents that cause a depletion of neuroactive peptides such as dopamine in nerve terminals and are used to treat chorea due to neurodegenerative diseases or dyskinesias due to neuroleptic medications (tardive dyskinesia).In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss the structural and pharmacokinetic differences between these agents, understanding how they modulate dopamine levels at hypersensitive D2 receptors, common in TD. The program emphasizes the importance of VMAT2 inhibition and its interaction with antipsychotic medications.This podcast was recorded and is being used with permission of the presenters.Learning ObjectiveAt the conclusion of this activity, participants should be better able to:Examine the pharmacologic differences between the various VMAT2 inhibitorsThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.50 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is supported by an educational grant from Neurocrine Biosciences.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/dare-to-move-beyond-symptom-improvement-schizophrenia-9781SummarySchizophrenia is a chronic and debilitating mental illness that significantly affects not only the health, well-being, and functioning of patients but also their surrounding environment. Promoting resilience is essential for enhancing health as well as treating mental health issues. A fresh perspective on schizophrenia emphasizes early intervention, symptom enhancement, relapse prevention, functional advancement, and quality of life improvement. The importance of personalized care to improve functional outcomes for individuals living with the condition gain insights into the DARE approach:Detection – The importance of early detection and intervention in reducing the burden of schizophrenia and increasing recovery chances.Adherence – Shared decision-making for optimal medication choice, focusing on balancing efficacy and minimizing adverse effects that can lead to nonadherence (e.g., sedation, weight gain).Recovery – Functional recovery, quality of life, and achieving personal life goals as key outcomes in treatment.Engagement – Supporting patients in leading purposeful and meaningful lives.In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss the DARE approach and how shifting the goals of schizophrenia treatment toward not just response and remission but full recovery and resilience, underscore a holistic approach to mental health.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Evaluate the latest advancements in functional domains for schizophrenia treatment.Discuss personalized treatment to improve functional outcomes for individuals living with schizophrenia.This activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.DiscloPlease visit http://naceonline.com to engage in more live and on demand CME/CE content.

Suite à l'interview que j'ai fait à la créatrice de la box littéraire hispanique Hispalibox lors de la Journée Mondiale du Podcast, je me suis rappellé d'une question qui m'a été posée par une élève:Est-il une bonne idée de lire Harry Potter en espagnol?Je te donne mon avis sur la question dans un épisode 100% en espagnol adapté à un niveau faux-débutant.

This podcast features an engaging discussion between Dr. David Victor and his patient, with long-standing PBC, on the patient's insights and experiences with her disease and treatment. The activity will enable participants to understand the importance of listening to patient perspectives when designing individualized care pathways to alleviate symptoms and improve quality of life.Launch Date: October 24, 2024Release Date: October 24, 2024Expiration Date: September 30, 2025FACULTYDavid W. Victor III, MDAssociate Professor of Clinical MedicineHouston Methodist Research InstituteAssociate Professor of Clinical MedicineWeill Cornell MedicineThis podcast provides accredited continuing education credits.  To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.https://www.practicepointcme.com/CMEHome/patient-voices-in-primary-biliary-cholangitis-a-ce-podcast-series-to-recognize-challenges-reduce-disparities-and-improve-outcomes

Lien du podcast sur Spotify : https://open.spotify.com/show/4CZI34WKHVrrOUBFQTviwx?si=457706e431ba4a0fLien du podcast sur Apple Podcast : https://podcasts.apple.com/fr/podcast/l%C3%A9cole-des-cr%C3%A9ateurs/id1433905570

Voici un extrait de l'interview que j'ai fait à la créatrice de la box littéraire hispanique "Hispalibox" dans le cadre du direct sur Youtube pour fêter la Journée Mondiale du Podcast.Le site d'Hispalibox.Les programmes pour apprendre l'espagnol avec moi.Ce Podcast pour Apprendre l'Espagnol s'adresse aux Débutants et Faux-débutants Francophones qui veulent Apprendre à Parler Espagnol avec une Méthode Immersive et Naturelle pour un projet d'Expatriation, pour prendre la Retraite en Espagne, Communiquer avec leur belle-famille hispanophone ou tout simplement pour le Plaisir d'Apprendre l'espagnol.Mon site: www.sicomprendo.netInstagram: @paloma.sicomprendo

Au programme :Google invente le podcast par IAo1, le chatbot qui réfléchit avant de répondreThierry Breton claque la porte de la commission européenneLe reste de l'actu (ReMarkable Paper Pro, Waymo vs Humain, Apple Private Cloud Compute…)Liens :

J'ai récemment décidé (un peu sur un coup de tête) de relancer ma chaîne Youtube que j'avais créé il y a 4 ans et que je n'alimentais pas trop.Pour fêter mon retour sur Youtube (et aussi le nouveau look de mon site web), j'ai animé un direct ou "live" sur Youtube pour te proposer des exercices pratiques sur 3 pièges fréquents de l'espagnol.Ici tu pourras écouter l'exercice sur les prépositions. Simple et efficace.Pour pratiquer la prononciation et les faux amis c'est par ici.Les programmes pour apprendre l'espagnol avec moi.Ce Podcast pour Apprendre l'Espagnol s'adresse aux Débutants et Faux-débutants Francophones qui veulent Apprendre à Parler Espagnol avec une Méthode Immersive et Naturelle pour un projet d'Expatriation, pour prendre la Retraite en Espagne, Communiquer avec leur belle-famille hispanophone ou tout simplement pour le Plaisir d'Apprendre l'espagnol.Mon site: www.sicomprendo.netInstagram: @paloma.sicomprendo

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/tackling-residual-risk-in-ascvd-and-ckd-9653SummaryInflammation plays a pivotal role in both cardiovascular and chronic kidney disease, making it a crucial target for reducing patient risk. In this focused 15-minute podcast, our experts break down the latest insights into how inflammation drives these conditions and explore innovative approaches to managing it.Listen to Dr. Ridker as he will delve into the critical role of inflammation in cardiovascular and chronic kidney disease, with a focus on the predictive value of hsCRP as a biomarker for ASCVD and CKD risk. Dr. Ridker explores emerging strategies to address inflammation, and how these advancements could potentially reduce cardiovascular risk and improve patient outcomes.Learning ObjectiveAt the conclusion of this activity, participants should be better able to:Recognize the role of hsCRP as a biomarker in evaluating the risk of ASCVD and CKDIdentify the role of current and emerging agents, based on their mechanism of action, to target inflammation and potentially reduce cardiovascular riskThis activity is accredited for CME/CE CreditAssociation of Black Cardiologists, Inc. (ABC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Association of Black Cardiologists, Inc. designates this enduring material for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and ABC. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which includes 0.25 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is supported by an independent medical educational grant from Novo Nordisk.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/circling-the-wagons-to-care-fibrosing-ilds-9649SummaryNavigating the challenges of fibrosing ILDs requires a team approach. In this podcast, explore the "Dream Team" of healthcare professionals who collaborate to address the diverse needs of patients with IPF, SSc-ILD, and PPF. From pulmonologists to therapists and beyond, uncover the critical roles each plays in managing comorbidities, symptoms, and overall well-being. Gain valuable insights on when to refer to a specialized ILD center for comprehensive care.Learning ObjectiveAt the conclusion of this activity, participants should be better able to:Integrate multidisciplinary management for patients with fibrosing ILDs to manage comorbidities and monitor for the need for specialty center referralThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours, which includes 0 hours of pharmacology.For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

This podcast features an engaging discussion between Dr. Douglas Dieterich and his patient, a 54-year-old woman with long-standing PBC, on the patient's insights and experiences with her disease and treatment. The activity will enable participants to understand the importance of listening to patient perspectives when designing individualized care pathways to alleviate symptoms and improve quality of life.Launch Date: August 21, 2024Release Date: August 21, 2024Expiration Date: July 31, 2025FACULTYDouglas Dieterich, MDDirector, Institute for Liver Medicine at Mount SinaiProfessor of Medicine, Icahn School of Medicine at Mount SinaiThis podcast provides accredited continuing education credits.  To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.https://www.practicepointcme.com/CMEHome/patient-voices-in-primary-biliary-cholangitis-a-ce-podcast-series-to-recognize-challenges-reduce-disparities-and-improve-outcomes

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/primary-care-questions-on-moderate-to-severe-asthma-9617SummaryTwo experts from distinct clinical backgrounds – a primary care physician and a pulmonology PA – answer the top 5 questions primary care clinicians have about moderate-to-severe asthma. These questions come from clinician learners at Conversations in Primary Care (CPC) and Emerging Challenges and Clinical Updates in Primary Care (ECCU) live-virtual symposia from May through August, 2024.In just 15 minutes, this podcast/webcast covers the latest on:New inhaler options: Albuterol/budesonide and smart therapy alternativesMontelukast: Weighing benefits against risks and boxed warningsBiomarkers: What to test and how to use the results to guide referralsBiologics: When to consider them and how to co-manage with specialistsPractical tips: Best practices for primary care clinicians in everyday asthma managementLearning ObjectivesUpon completion of this activity, learners should be able to:Evaluate patients with asthma to identify those with inflammatory phenotypes who are more likely to have exacerbations and severe diseaseEscalate care for patients with moderate-to-severe asthma uncontrolled on ICS-LABAThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours, which includes 0.25 hours of pharmacology.For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

On this special episode offering CPE Credits, Fred Goldstein Invites Danielle Roman, manager of clinical pharmacy services at Allegheny Health Network Cancer Institute to discuss Breast Cancer Breakthroughs: A Peek into the Pipeline. This activity is supported by an independent medical education grant from Novartis Pharmaceuticals Corporation and Merck Sharp and Dohme. AMCP is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Full instructions on how to claim CPE credits can be found here (https://acrobat.adobe.com/id/urn:aaid:sc:VA6C2:cce0dc42-2b1b-4e42-8543-d1c93730e81d) Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/